Sands Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $121M | Sell |
|
|||||
|
2022
Q4 | $279M | Sell |
|
|||||
|
2022
Q3 | $274M | Sell |
|
|||||
|
2022
Q2 | $278M | Sell |
|
|||||
|
2022
Q1 | $374M | Sell |
|
|||||
|
2021
Q4 | $483M | Sell |
|
|||||
|
2021
Q3 | $515M | Sell |
|
|||||
|
2021
Q2 | $436M | Buy |
|
|||||
|
2021
Q1 | $226M | Buy |
|
|||||
|
2020
Q4 | $167M | Sell |
|
|||||
|
2020
Q3 | $262M | Sell |
|
|||||
|
2020
Q2 | $696M | Sell |
|
|||||
|
2020
Q1 | $431M | Sell |
|
|||||
|
2019
Q4 | $588M | Buy |
|
|||||
|
2019
Q3 | $298M | Buy |
|
|||||
|
2019
Q2 | $536M | Sell |
|
|||||
|
2019
Q1 | $431M | Buy |
|
|||||
|
2018
Q4 | $338M | Buy |
|
|||||
|
2018
Q3 | $307M | Buy |
|